

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.78319458 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.14775236 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.83789486 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.50991781 |
| 5 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 5.44214160 |
| 6 | retinal cone cell development (GO:0046549) | 5.35869368 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.28588296 |
| 8 | rhodopsin mediated signaling pathway (GO:0016056) | 5.27570332 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.22034827 |
| 10 | nucleobase catabolic process (GO:0046113) | 5.18868851 |
| 11 | vocalization behavior (GO:0071625) | 5.18410578 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 4.87745691 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.84866906 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.74150926 |
| 15 | glutamate secretion (GO:0014047) | 4.69199207 |
| 16 | protein localization to synapse (GO:0035418) | 4.65731003 |
| 17 | axonal fasciculation (GO:0007413) | 4.56773419 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.50956508 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.36651002 |
| 20 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.35331755 |
| 21 | cell migration in hindbrain (GO:0021535) | 4.31737012 |
| 22 | behavioral response to nicotine (GO:0035095) | 4.27526964 |
| 23 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.25010666 |
| 24 | exploration behavior (GO:0035640) | 4.23903191 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.19295177 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.11543137 |
| 27 | cell proliferation in forebrain (GO:0021846) | 4.08656506 |
| 28 | neuron cell-cell adhesion (GO:0007158) | 4.05335825 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 4.03125429 |
| 30 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.02909529 |
| 31 | axon extension involved in axon guidance (GO:0048846) | 4.02909529 |
| 32 | photoreceptor cell development (GO:0042461) | 3.98346154 |
| 33 | detection of light stimulus involved in visual perception (GO:0050908) | 3.96075794 |
| 34 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.96075794 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.89714080 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.81068878 |
| 37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.80910390 |
| 38 | presynaptic membrane organization (GO:0097090) | 3.80406902 |
| 39 | eye photoreceptor cell development (GO:0042462) | 3.79499417 |
| 40 | establishment of mitochondrion localization (GO:0051654) | 3.77132910 |
| 41 | photoreceptor cell maintenance (GO:0045494) | 3.74827326 |
| 42 | sodium ion export (GO:0071436) | 3.73833311 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.71184459 |
| 44 | retinal ganglion cell axon guidance (GO:0031290) | 3.68463664 |
| 45 | proline transport (GO:0015824) | 3.67719087 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.67467280 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.66075930 |
| 48 | axon extension (GO:0048675) | 3.64976719 |
| 49 | camera-type eye morphogenesis (GO:0048593) | 3.60044187 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 3.59683355 |
| 51 | positive regulation of neurotransmitter transport (GO:0051590) | 3.56515688 |
| 52 | dendritic spine morphogenesis (GO:0060997) | 3.55199703 |
| 53 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.54543284 |
| 54 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.54543284 |
| 55 | neurotransmitter transport (GO:0006836) | 3.51360573 |
| 56 | positive regulation of membrane potential (GO:0045838) | 3.49095988 |
| 57 | positive regulation of gastrulation (GO:2000543) | 3.48324499 |
| 58 | short-term memory (GO:0007614) | 3.47786896 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38507608 |
| 60 | neuron-neuron synaptic transmission (GO:0007270) | 3.38496253 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.36588472 |
| 62 | membrane hyperpolarization (GO:0060081) | 3.35824147 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.32601388 |
| 64 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.32382025 |
| 65 | head development (GO:0060322) | 3.31705039 |
| 66 | phototransduction (GO:0007602) | 3.30677194 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 3.29984683 |
| 68 | neuromuscular process controlling posture (GO:0050884) | 3.28012379 |
| 69 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25472778 |
| 70 | gamma-aminobutyric acid transport (GO:0015812) | 3.25440432 |
| 71 | neuronal action potential propagation (GO:0019227) | 3.24450347 |
| 72 | mitochondrion transport along microtubule (GO:0047497) | 3.22882607 |
| 73 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.22882607 |
| 74 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.22870705 |
| 75 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21581660 |
| 76 | negative regulation of axon guidance (GO:1902668) | 3.21472450 |
| 77 | spinal cord association neuron differentiation (GO:0021527) | 3.21330872 |
| 78 | detection of light stimulus (GO:0009583) | 3.20977204 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20890298 |
| 80 | cell communication by electrical coupling (GO:0010644) | 3.20448008 |
| 81 | response to auditory stimulus (GO:0010996) | 3.19947135 |
| 82 | innervation (GO:0060384) | 3.19801698 |
| 83 | protein-chromophore linkage (GO:0018298) | 3.19118965 |
| 84 | glutamate receptor signaling pathway (GO:0007215) | 3.18363870 |
| 85 | spinal cord development (GO:0021510) | 3.17463898 |
| 86 | long-term memory (GO:0007616) | 3.16728545 |
| 87 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.16251173 |
| 88 | glycine transport (GO:0015816) | 3.15170052 |
| 89 | postsynaptic membrane organization (GO:0001941) | 3.14656361 |
| 90 | startle response (GO:0001964) | 3.13710161 |
| 91 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.13163079 |
| 92 | detection of visible light (GO:0009584) | 3.12333387 |
| 93 | activation of protein kinase A activity (GO:0034199) | 3.11203575 |
| 94 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.09161678 |
| 95 | positive regulation of synapse assembly (GO:0051965) | 3.08619331 |
| 96 | synaptic vesicle endocytosis (GO:0048488) | 3.08083406 |
| 97 | phototransduction, visible light (GO:0007603) | 3.07394273 |
| 98 | retinal rod cell development (GO:0046548) | 3.05640937 |
| 99 | regulation of vesicle fusion (GO:0031338) | 3.05119907 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 3.03736075 |
| 101 | regulation of neurotransmitter levels (GO:0001505) | 3.03542797 |
| 102 | response to pheromone (GO:0019236) | 3.03474229 |
| 103 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.02223340 |
| 104 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.98958308 |
| 105 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.98501202 |
| 106 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.98002837 |
| 107 | membrane depolarization during action potential (GO:0086010) | 2.97744539 |
| 108 | neuron recognition (GO:0008038) | 2.97555076 |
| 109 | negative regulation of catenin import into nucleus (GO:0035414) | 2.97114930 |
| 110 | neuronal stem cell maintenance (GO:0097150) | 2.96594614 |
| 111 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.95990830 |
| 112 | chemosensory behavior (GO:0007635) | 2.95356199 |
| 113 | auditory behavior (GO:0031223) | 2.94950825 |
| 114 | positive regulation of synapse maturation (GO:0090129) | 2.94372263 |
| 115 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93198913 |
| 116 | regulation of guanylate cyclase activity (GO:0031282) | 2.92700584 |
| 117 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.92223692 |
| 118 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.90442577 |
| 119 | regulation of synaptic plasticity (GO:0048167) | 2.90235029 |
| 120 | regulation of axon guidance (GO:1902667) | 2.89740070 |
| 121 | limb development (GO:0060173) | 2.88852507 |
| 122 | appendage development (GO:0048736) | 2.88852507 |
| 123 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.88275587 |
| 124 | intraspecies interaction between organisms (GO:0051703) | 2.87632924 |
| 125 | social behavior (GO:0035176) | 2.87632924 |
| 126 | response to histamine (GO:0034776) | 2.86042483 |
| 127 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.85856523 |
| 128 | neuron projection extension (GO:1990138) | 2.85621353 |
| 129 | calcium ion-dependent exocytosis (GO:0017156) | 2.85579182 |
| 130 | olfactory bulb development (GO:0021772) | 2.84636676 |
| 131 | pattern specification involved in kidney development (GO:0061004) | 2.84504823 |
| 132 | vesicle transport along microtubule (GO:0047496) | 2.83152870 |
| 133 | neuromuscular process controlling balance (GO:0050885) | 2.83103023 |
| 134 | dendrite morphogenesis (GO:0048813) | 2.83091598 |
| 135 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.81472941 |
| 136 | long-term synaptic potentiation (GO:0060291) | 2.81281586 |
| 137 | synapse assembly (GO:0007416) | 2.79647495 |
| 138 | visual perception (GO:0007601) | 2.78879163 |
| 139 | membrane depolarization (GO:0051899) | 2.78268882 |
| 140 | neuronal ion channel clustering (GO:0045161) | 2.77989587 |
| 141 | potassium ion homeostasis (GO:0055075) | 2.77424225 |
| 142 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.76382278 |
| 143 | forebrain neuron differentiation (GO:0021879) | 2.72741014 |
| 144 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.71726338 |
| 145 | cardiovascular system development (GO:0072358) | 2.71719169 |
| 146 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.66156182 |
| 147 | ganglion development (GO:0061548) | 2.65791753 |
| 148 | positive regulation of neuroblast proliferation (GO:0002052) | 2.65195330 |
| 149 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.58369435 |
| 150 | ephrin receptor signaling pathway (GO:0048013) | 2.57564169 |
| 151 | cell-cell junction maintenance (GO:0045217) | 2.57009055 |
| 152 | somite development (GO:0061053) | 2.56731676 |
| 153 | synaptic transmission, cholinergic (GO:0007271) | 2.56661076 |
| 154 | lens fiber cell development (GO:0070307) | 2.55219477 |
| 155 | dendrite development (GO:0016358) | 2.53291628 |
| 156 | establishment of planar polarity (GO:0001736) | 2.50560250 |
| 157 | establishment of tissue polarity (GO:0007164) | 2.50560250 |
| 158 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.49324503 |
| 159 | neuron migration (GO:0001764) | 2.46665540 |
| 160 | cranial nerve morphogenesis (GO:0021602) | 2.46416553 |
| 161 | urogenital system development (GO:0001655) | 2.44999630 |
| 162 | viral transcription (GO:0019083) | 2.43978796 |
| 163 | body morphogenesis (GO:0010171) | 2.43823724 |
| 164 | adult walking behavior (GO:0007628) | 2.43805300 |
| 165 | mechanosensory behavior (GO:0007638) | 2.42583174 |
| 166 | establishment of nucleus localization (GO:0040023) | 2.38898470 |
| 167 | convergent extension (GO:0060026) | 2.38698043 |
| 168 | hippocampus development (GO:0021766) | 2.36078568 |
| 169 | negative chemotaxis (GO:0050919) | 2.35095319 |
| 170 | central nervous system myelination (GO:0022010) | 2.35055262 |
| 171 | axon ensheathment in central nervous system (GO:0032291) | 2.35055262 |
| 172 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.33972450 |
| 173 | behavioral response to ethanol (GO:0048149) | 2.33929529 |
| 174 | regulation of microtubule-based movement (GO:0060632) | 2.32660151 |
| 175 | translational termination (GO:0006415) | 2.31737840 |
| 176 | regulation of synapse assembly (GO:0051963) | 2.29777191 |
| 177 | ribosomal small subunit assembly (GO:0000028) | 2.29758217 |
| 178 | neurofilament cytoskeleton organization (GO:0060052) | 2.29486404 |
| 179 | apical protein localization (GO:0045176) | 2.28271979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.63003188 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.71333204 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.30480636 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.80606686 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.80527766 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.74633930 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71984015 |
| 8 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.63335375 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57436655 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.51021514 |
| 11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.48329270 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47966563 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47966563 |
| 14 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44628508 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41659242 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36632175 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33861395 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30531073 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24341511 |
| 20 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22266778 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18501756 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.18469679 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.16469319 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10375540 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07972237 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01912975 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94702897 |
| 28 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.92394918 |
| 29 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85521766 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82670521 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81242412 |
| 32 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.78580650 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.62744155 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57111471 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56723540 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56529094 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55648028 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.53315349 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.49742851 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38540535 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38238048 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37959147 |
| 43 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.35095470 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34549332 |
| 45 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32809936 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31303536 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30148697 |
| 48 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29110094 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27995845 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26987503 |
| 51 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.23831565 |
| 52 | AR_19668381_ChIP-Seq_PC3_Human | 1.23545878 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23181409 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19997664 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18100340 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17970056 |
| 57 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17477482 |
| 58 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17061974 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16766962 |
| 60 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.16570412 |
| 61 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.15121216 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14690196 |
| 63 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14649249 |
| 64 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.14176031 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13536232 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13308750 |
| 67 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13112376 |
| 68 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12770047 |
| 69 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.12072006 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11137021 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10977589 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10066858 |
| 73 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09981631 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09760954 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09574617 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09034635 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08515453 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07840804 |
| 79 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07795637 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07499627 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07254301 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07226131 |
| 83 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.06329757 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06078313 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05398636 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04862205 |
| 87 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.03178215 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02859358 |
| 89 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.02629539 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02404520 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01922422 |
| 92 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.98659503 |
| 93 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98367093 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97777218 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97647313 |
| 96 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97611622 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97248269 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97216247 |
| 99 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97178895 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97056024 |
| 101 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96439540 |
| 102 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96180921 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96180921 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95956506 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95807561 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95391575 |
| 107 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94291370 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94157259 |
| 109 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93918434 |
| 110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93738063 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92810676 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90867027 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90802953 |
| 114 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89645452 |
| 115 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89430024 |
| 116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89244614 |
| 117 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.87785468 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86858914 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86089030 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85402644 |
| 121 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85402644 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85398366 |
| 123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84189154 |
| 124 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83599177 |
| 125 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.83226200 |
| 126 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80223566 |
| 127 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79592696 |
| 128 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.79559587 |
| 129 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.79286335 |
| 130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.79051151 |
| 131 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.77261447 |
| 132 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.75815156 |
| 133 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.74809937 |
| 134 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.74070115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.41190316 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 4.24798468 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.76106672 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.54921369 |
| 5 | MP0003880_abnormal_central_pattern | 3.48648061 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.33839655 |
| 7 | MP0004270_analgesia | 3.25749801 |
| 8 | MP0003011_delayed_dark_adaptation | 3.21393032 |
| 9 | MP0009745_abnormal_behavioral_response | 2.86182449 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.83125391 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.79317747 |
| 12 | MP0005253_abnormal_eye_physiology | 2.74743014 |
| 13 | MP0002064_seizures | 2.67936385 |
| 14 | MP0009046_muscle_twitch | 2.66123344 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.52350426 |
| 16 | MP0006072_abnormal_retinal_apoptosis | 2.50805695 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.44761745 |
| 18 | MP0001486_abnormal_startle_reflex | 2.43749865 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.42041084 |
| 20 | MP0010030_abnormal_orbit_morphology | 2.30298073 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.27193771 |
| 22 | MP0002272_abnormal_nervous_system | 2.25902675 |
| 23 | MP0002736_abnormal_nociception_after | 2.09003561 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 2.05155899 |
| 25 | MP0000049_abnormal_middle_ear | 1.95975712 |
| 26 | MP0004858_abnormal_nervous_system | 1.94182359 |
| 27 | MP0003121_genomic_imprinting | 1.92888729 |
| 28 | MP0003123_paternal_imprinting | 1.87659066 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.84252668 |
| 30 | MP0001293_anophthalmia | 1.83954319 |
| 31 | MP0000566_synostosis | 1.83608792 |
| 32 | MP0002822_catalepsy | 1.82067629 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.81686977 |
| 34 | MP0005257_abnormal_intraocular_pressure | 1.78363509 |
| 35 | MP0002229_neurodegeneration | 1.74175683 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.73315582 |
| 37 | MP0001984_abnormal_olfaction | 1.70852095 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.69887614 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.69779167 |
| 40 | MP0004133_heterotaxia | 1.68196064 |
| 41 | MP0003942_abnormal_urinary_system | 1.67925331 |
| 42 | MP0001970_abnormal_pain_threshold | 1.67637367 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.67514278 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.63859076 |
| 45 | MP0004885_abnormal_endolymph | 1.63853552 |
| 46 | MP0009053_abnormal_anal_canal | 1.63846484 |
| 47 | MP0002184_abnormal_innervation | 1.63648015 |
| 48 | MP0003136_yellow_coat_color | 1.62885834 |
| 49 | MP0005195_abnormal_posterior_eye | 1.61973172 |
| 50 | MP0002090_abnormal_vision | 1.61702583 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.60949347 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.60507524 |
| 53 | MP0005410_abnormal_fertilization | 1.60122625 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.59551095 |
| 55 | MP0008789_abnormal_olfactory_epithelium | 1.55616989 |
| 56 | MP0008569_lethality_at_weaning | 1.53538893 |
| 57 | MP0000778_abnormal_nervous_system | 1.52309093 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.49050354 |
| 59 | MP0002938_white_spotting | 1.41309368 |
| 60 | MP0003879_abnormal_hair_cell | 1.40983521 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.40719762 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.35744779 |
| 63 | MP0004924_abnormal_behavior | 1.35744779 |
| 64 | MP0002752_abnormal_somatic_nervous | 1.35656094 |
| 65 | MP0000026_abnormal_inner_ear | 1.33480039 |
| 66 | MP0003890_abnormal_embryonic-extraembry | 1.31902227 |
| 67 | MP0000955_abnormal_spinal_cord | 1.30846857 |
| 68 | MP0003938_abnormal_ear_development | 1.30381003 |
| 69 | MP0004233_abnormal_muscle_weight | 1.28631956 |
| 70 | MP0003329_amyloid_beta_deposits | 1.28313367 |
| 71 | MP0001286_abnormal_eye_development | 1.27266488 |
| 72 | MP0002233_abnormal_nose_morphology | 1.25840349 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.24890682 |
| 74 | MP0002249_abnormal_larynx_morphology | 1.24554065 |
| 75 | MP0003385_abnormal_body_wall | 1.24037657 |
| 76 | MP0003119_abnormal_digestive_system | 1.23912847 |
| 77 | MP0002697_abnormal_eye_size | 1.23708326 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 1.21862118 |
| 79 | MP0002653_abnormal_ependyma_morphology | 1.20549571 |
| 80 | MP0005377_hearing/vestibular/ear_phenot | 1.20389129 |
| 81 | MP0003878_abnormal_ear_physiology | 1.20389129 |
| 82 | MP0002638_abnormal_pupillary_reflex | 1.19390165 |
| 83 | MP0003122_maternal_imprinting | 1.17565444 |
| 84 | MP0001177_atelectasis | 1.16916587 |
| 85 | MP0003755_abnormal_palate_morphology | 1.16854400 |
| 86 | MP0001485_abnormal_pinna_reflex | 1.15394950 |
| 87 | MP0003937_abnormal_limbs/digits/tail_de | 1.12994228 |
| 88 | MP0001324_abnormal_eye_pigmentation | 1.12704609 |
| 89 | MP0003787_abnormal_imprinting | 1.12219258 |
| 90 | MP0005391_vision/eye_phenotype | 1.11647208 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 1.11540545 |
| 92 | MP0000569_abnormal_digit_pigmentation | 1.11223871 |
| 93 | MP0009250_abnormal_appendicular_skeleto | 1.10283199 |
| 94 | MP0002102_abnormal_ear_morphology | 1.09743161 |
| 95 | MP0000537_abnormal_urethra_morphology | 1.07473051 |
| 96 | MP0005503_abnormal_tendon_morphology | 1.06232335 |
| 97 | MP0002116_abnormal_craniofacial_bone | 1.04320529 |
| 98 | MP0002092_abnormal_eye_morphology | 1.04188308 |
| 99 | MP0002751_abnormal_autonomic_nervous | 1.03167541 |
| 100 | MP0005248_abnormal_Harderian_gland | 1.02832337 |
| 101 | MP0002152_abnormal_brain_morphology | 1.01917476 |
| 102 | MP0000428_abnormal_craniofacial_morphol | 1.01018976 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.98087542 |
| 104 | MP0001529_abnormal_vocalization | 0.97550169 |
| 105 | MP0005499_abnormal_olfactory_system | 0.97423985 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.97423985 |
| 107 | MP0003634_abnormal_glial_cell | 0.97374943 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.96533128 |
| 109 | MP0001905_abnormal_dopamine_level | 0.95278341 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.95036471 |
| 111 | MP0003633_abnormal_nervous_system | 0.94330376 |
| 112 | MP0001188_hyperpigmentation | 0.93311311 |
| 113 | MP0004742_abnormal_vestibular_system | 0.92992021 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.92703329 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.91668912 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.91551017 |
| 117 | MP0004142_abnormal_muscle_tone | 0.91025038 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.89473173 |
| 119 | MP0002081_perinatal_lethality | 0.86692644 |
| 120 | MP0004043_abnormal_pH_regulation | 0.82292113 |
| 121 | MP0003698_abnormal_male_reproductive | 0.81805987 |
| 122 | MP0001299_abnormal_eye_distance/ | 0.80819767 |
| 123 | MP0003631_nervous_system_phenotype | 0.80075303 |
| 124 | MP0000534_abnormal_ureter_morphology | 0.76273635 |
| 125 | MP0008872_abnormal_physiological_respon | 0.75969642 |
| 126 | MP0000751_myopathy | 0.75814166 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.75543984 |
| 128 | MP0004085_abnormal_heartbeat | 0.70822341 |
| 129 | MP0008004_abnormal_stomach_pH | 0.67209368 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.66042340 |
| 131 | MP0000013_abnormal_adipose_tissue | 0.60927636 |
| 132 | MP0001664_abnormal_digestion | 0.58386374 |
| 133 | MP0003172_abnormal_lysosome_physiology | 0.58247780 |
| 134 | MP0003632_abnormal_nervous_system | 0.57276656 |
| 135 | MP0001943_abnormal_respiration | 0.56868021 |
| 136 | MP0005187_abnormal_penis_morphology | 0.56515743 |
| 137 | MP0003045_fibrosis | 0.56408044 |
| 138 | MP0003283_abnormal_digestive_organ | 0.55568961 |
| 139 | MP0008877_abnormal_DNA_methylation | 0.55102622 |
| 140 | MP0003861_abnormal_nervous_system | 0.54313193 |
| 141 | MP0008874_decreased_physiological_sensi | 0.51606183 |
| 142 | MP0005535_abnormal_body_temperature | 0.50069458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 6.79783386 |
| 2 | Dyschromatopsia (HP:0007641) | 6.08852186 |
| 3 | Bony spicule pigmentary retinopathy (HP:0007737) | 6.03579716 |
| 4 | Central scotoma (HP:0000603) | 5.66160609 |
| 5 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.26093292 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 5.19315709 |
| 7 | Myokymia (HP:0002411) | 5.14302254 |
| 8 | Focal motor seizures (HP:0011153) | 4.99421693 |
| 9 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.89616027 |
| 10 | Scotoma (HP:0000575) | 4.89387315 |
| 11 | Pigmentary retinal degeneration (HP:0001146) | 4.09109668 |
| 12 | Chorioretinal atrophy (HP:0000533) | 4.07784342 |
| 13 | Focal seizures (HP:0007359) | 3.77760371 |
| 14 | Visual hallucinations (HP:0002367) | 3.76125558 |
| 15 | Attenuation of retinal blood vessels (HP:0007843) | 3.73235463 |
| 16 | Decreased central vision (HP:0007663) | 3.71485051 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.69819368 |
| 18 | Abolished electroretinogram (ERG) (HP:0000550) | 3.62527176 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.57537524 |
| 20 | Pendular nystagmus (HP:0012043) | 3.56043748 |
| 21 | Febrile seizures (HP:0002373) | 3.55798705 |
| 22 | Posterior subcapsular cataract (HP:0007787) | 3.44528293 |
| 23 | Choroideremia (HP:0001139) | 3.37547817 |
| 24 | Type II diabetes mellitus (HP:0005978) | 3.26647310 |
| 25 | Photophobia (HP:0000613) | 3.19104009 |
| 26 | Septo-optic dysplasia (HP:0100842) | 3.14280370 |
| 27 | Action tremor (HP:0002345) | 3.10533340 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.03762939 |
| 29 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.96540047 |
| 30 | Short 4th metacarpal (HP:0010044) | 2.96540047 |
| 31 | Abnormality of the 4th metacarpal (HP:0010012) | 2.81504695 |
| 32 | Severe visual impairment (HP:0001141) | 2.81300547 |
| 33 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.73340386 |
| 34 | Absent/shortened dynein arms (HP:0200106) | 2.73340386 |
| 35 | Macular degeneration (HP:0000608) | 2.73161593 |
| 36 | Genetic anticipation (HP:0003743) | 2.71787443 |
| 37 | Rib fusion (HP:0000902) | 2.71431819 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.69142765 |
| 39 | Ankle clonus (HP:0011448) | 2.67332107 |
| 40 | Anophthalmia (HP:0000528) | 2.64848593 |
| 41 | Atonic seizures (HP:0010819) | 2.61726593 |
| 42 | Postural instability (HP:0002172) | 2.58326632 |
| 43 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.57317300 |
| 44 | Hepatoblastoma (HP:0002884) | 2.55111994 |
| 45 | Abnormality of the aortic arch (HP:0012303) | 2.53662992 |
| 46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.53555374 |
| 47 | Truncal ataxia (HP:0002078) | 2.52346911 |
| 48 | Vitreoretinal degeneration (HP:0000655) | 2.52228479 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 2.47533892 |
| 50 | Depression (HP:0000716) | 2.44780717 |
| 51 | Retinitis pigmentosa (HP:0000510) | 2.43180158 |
| 52 | High anterior hairline (HP:0009890) | 2.42060560 |
| 53 | Absence seizures (HP:0002121) | 2.41874205 |
| 54 | Constricted visual fields (HP:0001133) | 2.39106995 |
| 55 | Morphological abnormality of the middle ear (HP:0008609) | 2.37606668 |
| 56 | Broad-based gait (HP:0002136) | 2.34391209 |
| 57 | Renovascular hypertension (HP:0100817) | 2.31630406 |
| 58 | Nephronophthisis (HP:0000090) | 2.31597395 |
| 59 | Optic nerve hypoplasia (HP:0000609) | 2.30896942 |
| 60 | Gaze-evoked nystagmus (HP:0000640) | 2.30359305 |
| 61 | Subcapsular cataract (HP:0000523) | 2.27508314 |
| 62 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.26214477 |
| 63 | Mutism (HP:0002300) | 2.23670502 |
| 64 | Pachygyria (HP:0001302) | 2.23152573 |
| 65 | Gait imbalance (HP:0002141) | 2.22210245 |
| 66 | Increased corneal curvature (HP:0100692) | 2.22107667 |
| 67 | Keratoconus (HP:0000563) | 2.22107667 |
| 68 | Pancreatic fibrosis (HP:0100732) | 2.21500672 |
| 69 | Polyphagia (HP:0002591) | 2.21093970 |
| 70 | Retinal atrophy (HP:0001105) | 2.19939739 |
| 71 | Chronic hepatic failure (HP:0100626) | 2.18396068 |
| 72 | Anxiety (HP:0000739) | 2.18197928 |
| 73 | Hyperventilation (HP:0002883) | 2.18131963 |
| 74 | Cone-rod dystrophy (HP:0000548) | 2.15262772 |
| 75 | Abnormality of the diencephalon (HP:0010662) | 2.13173348 |
| 76 | Abnormal number of incisors (HP:0011064) | 2.12462467 |
| 77 | Renal duplication (HP:0000075) | 2.12262913 |
| 78 | Dialeptic seizures (HP:0011146) | 2.12107529 |
| 79 | Oligodactyly (HP:0012165) | 2.11529693 |
| 80 | Partial duplication of thumb phalanx (HP:0009944) | 2.11242593 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.10229542 |
| 82 | Abnormality of midbrain morphology (HP:0002418) | 2.10229542 |
| 83 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.07258380 |
| 84 | Oligodactyly (hands) (HP:0001180) | 2.06944309 |
| 85 | Partial duplication of the phalanx of hand (HP:0009999) | 2.03847939 |
| 86 | Neonatal short-limb short stature (HP:0008921) | 2.03394415 |
| 87 | Cutaneous finger syndactyly (HP:0010554) | 2.02178941 |
| 88 | Elfin facies (HP:0004428) | 2.01943986 |
| 89 | Turricephaly (HP:0000262) | 2.01609630 |
| 90 | Agitation (HP:0000713) | 2.00927354 |
| 91 | Absent speech (HP:0001344) | 1.99745737 |
| 92 | Abnormal eating behavior (HP:0100738) | 1.98532223 |
| 93 | Poor eye contact (HP:0000817) | 1.98484619 |
| 94 | Abnormality of the lower motor neuron (HP:0002366) | 1.98476922 |
| 95 | Megalencephaly (HP:0001355) | 1.97555287 |
| 96 | Intestinal atresia (HP:0011100) | 1.96136465 |
| 97 | Excessive salivation (HP:0003781) | 1.95061771 |
| 98 | Drooling (HP:0002307) | 1.95061771 |
| 99 | Cutaneous syndactyly (HP:0012725) | 1.94850746 |
| 100 | Congenital primary aphakia (HP:0007707) | 1.93787961 |
| 101 | Dysmetria (HP:0001310) | 1.93050985 |
| 102 | Broad metatarsal (HP:0001783) | 1.92688797 |
| 103 | Limb dystonia (HP:0002451) | 1.91193886 |
| 104 | Pheochromocytoma (HP:0002666) | 1.91034962 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 1.90412983 |
| 106 | Urinary urgency (HP:0000012) | 1.89561852 |
| 107 | Bradykinesia (HP:0002067) | 1.89516925 |
| 108 | Absent septum pellucidum (HP:0001331) | 1.88631741 |
| 109 | Genital tract atresia (HP:0001827) | 1.88441094 |
| 110 | Medial flaring of the eyebrow (HP:0010747) | 1.88412664 |
| 111 | Torticollis (HP:0000473) | 1.87541286 |
| 112 | Anencephaly (HP:0002323) | 1.86618513 |
| 113 | Abnormal social behavior (HP:0012433) | 1.86337069 |
| 114 | Impaired social interactions (HP:0000735) | 1.86337069 |
| 115 | Occipital encephalocele (HP:0002085) | 1.84539885 |
| 116 | Ventricular fibrillation (HP:0001663) | 1.84393838 |
| 117 | Adrenal hypoplasia (HP:0000835) | 1.83956249 |
| 118 | Shawl scrotum (HP:0000049) | 1.83630725 |
| 119 | Bladder diverticulum (HP:0000015) | 1.82537829 |
| 120 | Horizontal nystagmus (HP:0000666) | 1.82389089 |
| 121 | Abnormality of abdominal situs (HP:0011620) | 1.82085165 |
| 122 | Abdominal situs inversus (HP:0003363) | 1.82085165 |
| 123 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.81497545 |
| 124 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.81497545 |
| 125 | Hyperglycinemia (HP:0002154) | 1.81291319 |
| 126 | Spastic gait (HP:0002064) | 1.80855952 |
| 127 | Broad phalanges of the hand (HP:0009768) | 1.80567497 |
| 128 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.79882515 |
| 129 | Hypoplasia of the brainstem (HP:0002365) | 1.79882515 |
| 130 | Broad finger (HP:0001500) | 1.79700609 |
| 131 | True hermaphroditism (HP:0010459) | 1.79564333 |
| 132 | Broad long bones (HP:0005622) | 1.79488668 |
| 133 | Abnormality of the renal medulla (HP:0100957) | 1.78891745 |
| 134 | Abnormality of the intervertebral disk (HP:0005108) | 1.78715392 |
| 135 | Scanning speech (HP:0002168) | 1.77794721 |
| 136 | Reticulocytopenia (HP:0001896) | 1.77072941 |
| 137 | Overriding aorta (HP:0002623) | 1.77043146 |
| 138 | Papilledema (HP:0001085) | 1.76875780 |
| 139 | Impaired smooth pursuit (HP:0007772) | 1.76654642 |
| 140 | Cortical dysplasia (HP:0002539) | 1.76613910 |
| 141 | Sleep apnea (HP:0010535) | 1.76539908 |
| 142 | Abnormality of dentin (HP:0010299) | 1.76362743 |
| 143 | Hypoventilation (HP:0002791) | 1.76120500 |
| 144 | Coronal craniosynostosis (HP:0004440) | 1.76042354 |
| 145 | Spastic tetraplegia (HP:0002510) | 1.75080079 |
| 146 | Hypoplasia of the ulna (HP:0003022) | 1.74538470 |
| 147 | Hemiplegia (HP:0002301) | 1.74408141 |
| 148 | Maternal diabetes (HP:0009800) | 1.74267536 |
| 149 | Abnormal pancreas size (HP:0012094) | 1.74209085 |
| 150 | Amblyopia (HP:0000646) | 1.74085537 |
| 151 | Sclerocornea (HP:0000647) | 1.73993659 |
| 152 | Broad phalanx (HP:0006009) | 1.73504616 |
| 153 | Aplasia involving bones of the extremities (HP:0009825) | 1.71788670 |
| 154 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.71788670 |
| 155 | Aplasia of the phalanges of the hand (HP:0009802) | 1.71788670 |
| 156 | Lower limb muscle weakness (HP:0007340) | 1.71724763 |
| 157 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.70647406 |
| 158 | Synostosis of carpal bones (HP:0005048) | 1.70514737 |
| 159 | Fetal akinesia sequence (HP:0001989) | 1.70215314 |
| 160 | Fibular hypoplasia (HP:0003038) | 1.68931203 |
| 161 | Renal dysplasia (HP:0000110) | 1.68834677 |
| 162 | Supernumerary spleens (HP:0009799) | 1.68684268 |
| 163 | Hemiparesis (HP:0001269) | 1.68608574 |
| 164 | Bowel diverticulosis (HP:0005222) | 1.68036742 |
| 165 | Progressive visual loss (HP:0000529) | 1.67213796 |
| 166 | Postaxial hand polydactyly (HP:0001162) | 1.67180779 |
| 167 | Congenital sensorineural hearing impairment (HP:0008527) | 1.66800560 |
| 168 | Broad thumb (HP:0011304) | 1.66606533 |
| 169 | Specific learning disability (HP:0001328) | 1.66504891 |
| 170 | Intention tremor (HP:0002080) | 1.65736370 |
| 171 | Vaginal atresia (HP:0000148) | 1.65248067 |
| 172 | Wide anterior fontanel (HP:0000260) | 1.65213046 |
| 173 | Abnormal EKG (HP:0003115) | 1.64760353 |
| 174 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.64680589 |
| 175 | Poor coordination (HP:0002370) | 1.64651148 |
| 176 | Renal hypoplasia (HP:0000089) | 1.64095120 |
| 177 | Focal dystonia (HP:0004373) | 1.64085044 |
| 178 | Insomnia (HP:0100785) | 1.63880297 |
| 179 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.63833604 |
| 180 | Abnormality of the labia minora (HP:0012880) | 1.62688266 |
| 181 | Hypoplastic pelvis (HP:0008839) | 1.62227448 |
| 182 | Hemivertebrae (HP:0002937) | 1.62133245 |
| 183 | Soft skin (HP:0000977) | 1.62075231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.00673315 |
| 2 | EPHB2 | 3.73913788 |
| 3 | PRKD3 | 3.26768372 |
| 4 | MAP3K9 | 3.26143277 |
| 5 | MARK1 | 3.02895835 |
| 6 | MAP3K4 | 2.91090839 |
| 7 | EPHA4 | 2.87671748 |
| 8 | MINK1 | 2.77668869 |
| 9 | DYRK2 | 2.72147684 |
| 10 | MAP2K7 | 2.39773457 |
| 11 | PAK6 | 2.21757153 |
| 12 | STK38 | 2.21683885 |
| 13 | NTRK2 | 2.03997084 |
| 14 | MAP3K12 | 1.95525730 |
| 15 | LMTK2 | 1.83014067 |
| 16 | BCR | 1.79559705 |
| 17 | MAP2K4 | 1.78337292 |
| 18 | GRK1 | 1.77393826 |
| 19 | EPHA3 | 1.77156560 |
| 20 | NTRK1 | 1.76590028 |
| 21 | DAPK2 | 1.73620393 |
| 22 | CAMKK1 | 1.71693976 |
| 23 | SIK2 | 1.55047979 |
| 24 | DYRK3 | 1.53058662 |
| 25 | DYRK1B | 1.48704522 |
| 26 | KSR2 | 1.48014036 |
| 27 | CDK5 | 1.46414941 |
| 28 | LATS2 | 1.41143609 |
| 29 | CASK | 1.34923537 |
| 30 | PINK1 | 1.33107368 |
| 31 | MAPK13 | 1.31758896 |
| 32 | TNIK | 1.30841778 |
| 33 | GRK5 | 1.30205074 |
| 34 | SGK223 | 1.23645822 |
| 35 | SGK494 | 1.23645822 |
| 36 | PLK2 | 1.22681696 |
| 37 | KSR1 | 1.22543393 |
| 38 | MAPK15 | 1.22183181 |
| 39 | SGK2 | 1.21814268 |
| 40 | PNCK | 1.21611307 |
| 41 | PHKG2 | 1.19907748 |
| 42 | PHKG1 | 1.19907748 |
| 43 | PRKCG | 1.16330497 |
| 44 | NEK2 | 1.13886747 |
| 45 | SGK3 | 1.10954571 |
| 46 | CAMK1D | 1.09143782 |
| 47 | ICK | 1.07953022 |
| 48 | PRKCH | 1.03386408 |
| 49 | CAMK1G | 1.02762377 |
| 50 | PRPF4B | 1.02423716 |
| 51 | TYRO3 | 0.99869028 |
| 52 | DDR2 | 0.98941806 |
| 53 | TAOK1 | 0.97149189 |
| 54 | PDK3 | 0.94721791 |
| 55 | PDK4 | 0.94721791 |
| 56 | TIE1 | 0.94377582 |
| 57 | LIMK1 | 0.93976919 |
| 58 | MAP3K2 | 0.93635007 |
| 59 | ARAF | 0.93214202 |
| 60 | FES | 0.92542011 |
| 61 | RET | 0.91617190 |
| 62 | CAMK1 | 0.91264664 |
| 63 | DAPK1 | 0.90386460 |
| 64 | TNK2 | 0.88765476 |
| 65 | TESK1 | 0.88197255 |
| 66 | WNK1 | 0.86623859 |
| 67 | MUSK | 0.84615463 |
| 68 | STK11 | 0.80316729 |
| 69 | CSNK1G3 | 0.79868653 |
| 70 | CAMK2A | 0.79147212 |
| 71 | PKN1 | 0.78390442 |
| 72 | CDK18 | 0.77614847 |
| 73 | PAK3 | 0.77215214 |
| 74 | PIK3CA | 0.77149238 |
| 75 | CDK15 | 0.76671391 |
| 76 | CSNK1A1L | 0.75195235 |
| 77 | CDK14 | 0.74891163 |
| 78 | MARK2 | 0.73046251 |
| 79 | WNK3 | 0.71654665 |
| 80 | ADRBK2 | 0.70811806 |
| 81 | PTK2B | 0.70396970 |
| 82 | UHMK1 | 0.70338085 |
| 83 | MAP4K2 | 0.69270933 |
| 84 | AKT3 | 0.68857035 |
| 85 | NEK1 | 0.68803516 |
| 86 | SGK1 | 0.67720876 |
| 87 | FER | 0.67651258 |
| 88 | CDK11A | 0.66164901 |
| 89 | CSNK1G2 | 0.66053049 |
| 90 | SIK3 | 0.65795220 |
| 91 | WNK4 | 0.65749050 |
| 92 | IRAK2 | 0.65652701 |
| 93 | ALK | 0.65601993 |
| 94 | NEK6 | 0.65282868 |
| 95 | CSNK1G1 | 0.64835795 |
| 96 | PRKCZ | 0.63707125 |
| 97 | ADRBK1 | 0.61801328 |
| 98 | DYRK1A | 0.61357701 |
| 99 | RPS6KA2 | 0.60490268 |
| 100 | SCYL2 | 0.60392961 |
| 101 | RIPK4 | 0.60086599 |
| 102 | MAP3K11 | 0.57411505 |
| 103 | PDK1 | 0.57088084 |
| 104 | PDGFRA | 0.56115694 |
| 105 | CDC42BPA | 0.55923963 |
| 106 | MKNK2 | 0.54895953 |
| 107 | SIK1 | 0.54665149 |
| 108 | RPS6KA3 | 0.54586411 |
| 109 | CSNK1E | 0.54000119 |
| 110 | RIPK1 | 0.51949178 |
| 111 | MAP3K1 | 0.51688962 |
| 112 | CDK19 | 0.50999806 |
| 113 | DMPK | 0.50861586 |
| 114 | ABL2 | 0.49814504 |
| 115 | RPS6KA6 | 0.49491484 |
| 116 | CAMK4 | 0.48924397 |
| 117 | MAP3K6 | 0.48672184 |
| 118 | RPS6KL1 | 0.47971666 |
| 119 | RPS6KC1 | 0.47971666 |
| 120 | STK38L | 0.47361384 |
| 121 | FGFR2 | 0.47155348 |
| 122 | MAPK10 | 0.46976643 |
| 123 | STK39 | 0.46972302 |
| 124 | MAP3K13 | 0.45890724 |
| 125 | PDPK1 | 0.44453030 |
| 126 | PRKCE | 0.44374642 |
| 127 | MAP3K10 | 0.44329566 |
| 128 | PRKACA | 0.43780508 |
| 129 | ERBB2 | 0.43316470 |
| 130 | INSRR | 0.43118201 |
| 131 | TLK1 | 0.42654659 |
| 132 | ROCK1 | 0.42347937 |
| 133 | PRKCB | 0.42137769 |
| 134 | OXSR1 | 0.38736726 |
| 135 | PDK2 | 0.38293360 |
| 136 | PAK2 | 0.38195395 |
| 137 | MTOR | 0.37238938 |
| 138 | CAMKK2 | 0.37168545 |
| 139 | DAPK3 | 0.36857832 |
| 140 | FYN | 0.36543756 |
| 141 | PRKAA1 | 0.36464388 |
| 142 | ROCK2 | 0.36219063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.44575939 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.51933761 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.94781298 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.84548099 |
| 5 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.62611808 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.41365032 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.29521199 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20001010 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.18163182 |
| 10 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.17193244 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15261261 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.05946957 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99213525 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.98618059 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.98449856 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.98403416 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91902945 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.90937813 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.88746608 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82610955 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80643643 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.78983288 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.64815508 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.62752787 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52508524 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51056488 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49407721 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48994002 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46605593 |
| 30 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.45014087 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41729655 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.41042000 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.40047116 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38866201 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.38013857 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.36047823 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35722792 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34925984 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34751698 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33677801 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30692937 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14967954 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12205247 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09946695 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09204109 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 1.08260201 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06107094 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05100696 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04622420 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04530785 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04072871 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.03776364 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 1.00849133 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00345434 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00285750 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00120901 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 0.97979829 |
| 58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97877228 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95786401 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95317268 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91938139 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91129936 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91055634 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90486257 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.89239779 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.86408302 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85410847 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84215773 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83916269 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81064959 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80545921 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78131963 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75288451 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74910562 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72863308 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72807059 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71124597 |
| 78 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70438468 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69973495 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69112587 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67272540 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66729739 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65670339 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64905953 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63735153 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63451576 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63369851 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63213466 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62890366 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61630650 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60447118 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59001893 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57553784 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56825399 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56637578 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56423244 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56171352 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55461657 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.54235449 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54037485 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53592608 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53089861 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52771404 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52578633 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52542020 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.52115163 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52102125 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.51856512 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51482275 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51115391 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49503385 |
| 112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49249464 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47980458 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47097519 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46974756 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46943043 |
| 117 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46617328 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46003607 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45612094 |
| 120 | Bile secretion_Homo sapiens_hsa04976 | 0.45099392 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44682513 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | 0.44420439 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43224446 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.42707836 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41969304 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41886853 |
| 127 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41740898 |
| 128 | Focal adhesion_Homo sapiens_hsa04510 | 0.41330502 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41078451 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41020111 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40556295 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39757769 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38653061 |
| 134 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38582644 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37169773 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.37152460 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36080849 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34737175 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33704624 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33287171 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.33022358 |
| 142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30091679 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29527831 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27863899 |
| 145 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27482029 |

